Naftifina Atb (Naftifine Hydrochloride)

Naftifine Hydrochloride, the active ingredient in Naftifina Atb, is an allylamine antifungal presented as a topical formulation for skin application. It is used to treat superficial fungal infections, including athlete’s foot, ringworm, jock itch and tinea versicolor, in both adult and pediatric patients.

GNH USA supplies Naftifina Atb as a licensed, GDP‑compliant international pharmaceutical supplier, sourcing the product from EU‑regulated manufacturers and delivering to hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Naftifine Hydrochloride is applied topically to treat fungal skin infections within the dermatophyte and yeast disease family.

- Tinea pedis: Reduces itching, scaling and erythema associated with athlete’s foot. - Tinea corporis: Clears ring‑shaped lesions and prevents spread of infection. - Tinea cruris: Relieves inflammation and resolves jock itch symptoms. - Tinea versicolor: Improves discoloration and normalizes skin pigmentation. - Superficial dermatophyte infections: Eradicates fungal growth on the skin surface.

Topical application of Naftifine Hydrochloride may be associated with local skin reactions.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Burning: transient heat sensation after application. - Stinging: brief sharp discomfort. - Redness: localized erythema. - Dry skin: mild desiccation of treated area. - Contact dermatitis: mild allergic skin reaction.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Extensive skin irritation: intense redness or swelling beyond the treated area. - Angioedema: rapid swelling of lips, tongue or face. - Anaphylaxis: life‑threatening systemic allergic response. - Stevens‑Johnson syndrome: rare severe skin disorder. - Toxic epidermal necrolysis: extremely rare, severe skin detachment.

Before using Naftifine Hydrochloride, consider the following safety measures.

- Avoid use on broken skin: limit application to intact epidermis. - Do not apply to mucous membranes: keep product away from eyes, mouth and genital mucosa. - Discontinue if severe irritation occurs: stop treatment and seek medical advice. - Consult a healthcare professional before use in children under 2 years: pediatric safety not fully established. - Avoid concurrent use with other topical irritants or corticosteroids unless directed: may increase risk of irritation or reduce efficacy. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Naftifine Hydrochloride has a limited interaction profile, but certain combinations may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use with other topical antifungal agents: may increase local irritation. - Application over skin treated with chemical peels or abrasive agents: heightened risk of dermatitis.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may diminish antifungal effectiveness. - Use with skin products containing alcohol, fragrances or harsh preservatives: can exacerbate local irritation. - Simultaneous use of systemic antifungals that affect CYP450 enzymes: monitor for systemic side‑effects, although topical absorption is minimal.